Fujifilm Medical Systems U.S.A., Inc.’s Synapse VNA has achieved a milestone, having reached more than 300 oncology sites throughout the world. Synapse VNA manages clinical oncology department data, which includes both DICOM and non-DICOM data, such as radiology diagnostic images, radiation treatment plans, and other clinical data that’s helpful in the treatment of cancer patients.
“Fujifilm truly dominates the oncology VNA space both for our innovative technology and also our knowledge of what it takes to deliver better cancer care,” says Greg Strowig, vice president of Fujifilm’s TeraMedica division. “Cancer centers across the globe have turned to us because of our unparalleled experience with the management of cancer treatment data.”
Johns Hopkins, which is one of 45 cancer centers in the country that’s been designated by the National Cancer Center, implemented Synapse VNA seven years ago. Another customer site is the Moffitt Cancer Center, which was ranked as the No. 6 cancer center in the country in U.S. News & World Report’s 2016 annual report of top cancer hospitals. Moffitt is currently installing the system, according to Fujifilm personnel.
For more information about these installations, visit Fujifilm.
